tirzepatide diabetic retinopathy risk May Lower of | Professor Erwin Loh posted on the topic Although rare, GLP-1s tied to
Description
In head-to-head trial data (SURPASS-2), this dual mechanism was associated with greater average weight loss and glycaemic control than a GLP-1-only comparator
Treatment depends on cause and may involve referral to urology
FDA-approved as Zepbound for chronic weight management in adults with obesity
Plus I take other products from Citizen Meds
Taking a break from tirzepatide allows its effects on appetite and blood sugar to wear off over time
